info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Ischemic Stroke Surgery Companies

Ischemic stroke surgery typically involves medical interventions rather than traditional surgery. The primary goal is to restore blood flow to the affected part of the brain, often using medications or endovascular procedures.

Ischemic Stroke Surgery Key CompaniesLatest Ischemic Stroke Surgery Companies Update



  • Jan 2023: Positive results from the TARGET research of the TheraSphere Y-90 Glass Microspheres for individuals with hepatocellular carcinoma (HCC), a prevalent form of primary liver cancer, have been released by Boston Scientific. A form of radioembolization known as TheraSphere comprises millions of tiny glass beads that are radioactively yttrium (Y-90). TheraSphere is the only radioembolization method recommended for treating incurable HCC in the US. Using a dosage technique known as multicompartment dosimetry, the worldwide, retrospective TARGET research examined the safety and effectiveness of TheraSphere therapy in patients with HCC. This reduces the amount of radiation that reaches healthy liver tissue while increasing the amount of Y-90 that reaches the tumor.




  • June 2023: Penumbra, Inc., a multinational healthcare organization specializing in cutting-edge treatments, has announced that Lightning BoltTM 7, the most potent and sophisticated artery thrombectomy system available, has received FDA approval and is now available for purchase. With Lightning Bolt 7, a novel approach to removing blood clots is presented: modulated aspiration, which combines a sophisticated microprocessor algorithm with Penumbra's Lightning Intelligent Aspiration technology. When combined, Lightning Bolt 7 is intended to improve the capacity to quickly eliminate big, fibrous blood clots from the arteries and with little blood loss, treating diseases such as visceral occlusions, hibernating thrombus, and acute limb ischemia (ALI).


List of Ischemic Stroke Surgery Key companies in the market

  • Stryker (US)

  • Medtronic Plc (Ireland)

  • Johnson & Johnson Services Inc. (US)

  • Boston Scientific Corporation (US)

  • Penumbra, Inc. (US)

  • Abbott Laboratories (US)

  • Koninklijke Philips N.V. (Netherlands)

  • Imperative Care (US)

  • Phenox GmbH (Germany)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.